10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb.
about
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationDoping in sport: effects, harm and misconceptions.Short hairpin RNA gene silencing of prolyl hydroxylase-2 with a minicircle vector improves neovascularization of hindlimb ischemia.Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia.Effects of survivin on angiogenesis in vivo and in vitro.Late responses to adenoviral-mediated transfer of the aquaporin-1 gene for radiation-induced salivary hypofunction.Cancer immunotherapy: a paradigm shift for prostate cancer treatment.Nonviral gene therapy targeting cardiovascular system.Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success.Medical management of critical limb ischaemia: where do we stand today?Current gene therapy trials for vascular diseases.Limb ischemia: cardiovascular diagnosis and management from head to toe.Current therapies and investigational drugs for peripheral arterial disease.Cardiovascular Gene Therapy: Past, Present, and Future.PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle.Gene delivery nanoparticles to modulate angiogenesis.Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart.Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease.Angiogenic gene therapy in cardiovascular diseases: dream or vision?Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice.Effects of VEGF and MSCs on vascular regeneration in a trauma model in rats.
P2860
Q26799437-01FA1821-3337-44CE-BCB5-24EF77DB4D2EQ34446275-36ABCEB1-E116-41C1-9C51-194B078B4AD6Q35007366-D9A2DFF9-D5D6-4DC2-90FB-B139D7F6CC96Q35582797-0A26CBCB-51A9-4F63-B34A-02B6B717BC28Q36841092-C66C0195-C550-48C3-8060-DE9AF49BDE8DQ37730757-7B631597-6544-44D7-80C0-4C96F41EB2CAQ38013964-AABB7263-4425-4C5F-B90B-B370E67A2A29Q38028448-69AB06CA-B85F-49D4-8330-1801C93EFCBAQ38087578-4349FF08-975F-4C96-83B6-03986509B3E3Q38116561-F4674406-6446-45C1-932E-6044874BD1B8Q38175483-BCF546C9-89B5-48F5-A5F1-B57A1ADE64D8Q38511050-2289A2F3-A2A2-416C-9C4E-8B152354725FQ38657444-A8A775C5-5B5C-4186-A683-77B5020D7D51Q38733395-E31E0E29-ACE2-4C62-845F-F830ABEE59C6Q38976780-0BF8E9D3-1DD6-4A3B-873D-1A6E0D6679AEQ39027588-0747067C-FAE0-44F9-B022-DF68FCE9ECD2Q41021093-45A10A8B-EE55-4968-BFFB-4325E51A8DE3Q42181707-54CAA49F-ECB7-4617-A08C-A13CB59C9F82Q45863499-83F65CCF-3134-4059-A39B-E5483E4F002EQ47759603-8510CCDC-D160-47B9-B904-AF5FB880DC77Q53589166-DBCCD582-999E-49F4-95A1-920C2E2F3848
P2860
10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
10-year safety follow-up in pa ...... ansfer to ischemic lower limb.
@en
10-year safety follow-up in pa ...... ansfer to ischemic lower limb.
@nl
type
label
10-year safety follow-up in pa ...... ansfer to ischemic lower limb.
@en
10-year safety follow-up in pa ...... ansfer to ischemic lower limb.
@nl
prefLabel
10-year safety follow-up in pa ...... ansfer to ischemic lower limb.
@en
10-year safety follow-up in pa ...... ansfer to ischemic lower limb.
@nl
P2093
P2860
P356
P1433
P1476
10-year safety follow-up in pa ...... ansfer to ischemic lower limb.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2011.109
P577
2011-07-21T00:00:00Z
P6179
1002488558